These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 28913345

  • 1. A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness.
    Lista MJ, Martins RP, Angrand G, Quillévéré A, Daskalogianni C, Voisset C, Teulade-Fichou MP, Fåhraeus R, Blondel M.
    Microb Cell; 2017 Aug 31; 4(9):305-307. PubMed ID: 28913345
    [Abstract] [Full Text] [Related]

  • 2. Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune system.
    Angrand G, Quillévéré A, Loaëc N, Dinh VT, Le Sénéchal R, Chennoufi R, Duchambon P, Keruzoré M, Martins RP, Teulade-Fichou MP, Fåhraeus R, Blondel M.
    Nucleic Acids Res; 2022 Nov 11; 50(20):11799-11819. PubMed ID: 36350639
    [Abstract] [Full Text] [Related]

  • 3. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
    Lista MJ, Martins RP, Billant O, Contesse MA, Findakly S, Pochard P, Daskalogianni C, Beauvineau C, Guetta C, Jamin C, Teulade-Fichou MP, Fåhraeus R, Voisset C, Blondel M.
    Nat Commun; 2017 Jul 07; 8():16043. PubMed ID: 28685753
    [Abstract] [Full Text] [Related]

  • 4. Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.
    Reznichenko O, Quillévéré A, Martins RP, Loaëc N, Kang H, Lista MJ, Beauvineau C, González-García J, Guillot R, Voisset C, Daskalogianni C, Fåhraeus R, Teulade-Fichou MP, Blondel M, Granzhan A.
    Eur J Med Chem; 2019 Sep 15; 178():13-29. PubMed ID: 31173968
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C, Pyndiah S, Apcher S, Mazars A, Manoury B, Ammari N, Nylander K, Voisset C, Blondel M, Fåhraeus R.
    J Pathol; 2015 Jan 15; 235(2):334-41. PubMed ID: 25186125
    [Abstract] [Full Text] [Related]

  • 7. The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale.
    Dinh VT, Loaëc N, Quillévéré A, Le Sénéchal R, Keruzoré M, Martins RP, Granzhan A, Blondel M.
    Biochimie; 2023 Nov 15; 214(Pt A):57-68. PubMed ID: 37473831
    [Abstract] [Full Text] [Related]

  • 8. EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.
    Wilson JB, Manet E, Gruffat H, Busson P, Blondel M, Fahraeus R.
    Cancers (Basel); 2018 Apr 06; 10(4):. PubMed ID: 29642420
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
    Blake NW, Moghaddam A, Rao P, Kaur A, Glickman R, Cho YG, Marchini A, Haigh T, Johnson RP, Rickinson AB, Wang F.
    J Virol; 1999 Sep 06; 73(9):7381-9. PubMed ID: 10438828
    [Abstract] [Full Text] [Related]

  • 10. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.
    Chen YL, Liu CD, Cheng CP, Zhao B, Hsu HJ, Shen CL, Chiu SJ, Kieff E, Peng CW.
    Proc Natl Acad Sci U S A; 2014 Jan 07; 111(1):243-8. PubMed ID: 24344309
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.
    Mautner J, Pich D, Nimmerjahn F, Milosevic S, Adhikary D, Christoph H, Witter K, Bornkamm GW, Hammerschmidt W, Behrends U.
    Eur J Immunol; 2004 Sep 07; 34(9):2500-9. PubMed ID: 15307182
    [Abstract] [Full Text] [Related]

  • 12. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.
    Tellam JT, Lekieffre L, Zhong J, Lynn DJ, Khanna R.
    PLoS Pathog; 2012 Dec 07; 8(12):e1003112. PubMed ID: 23300450
    [Abstract] [Full Text] [Related]

  • 13. Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune Evasion.
    Angrand G, Quillévéré A, Loaëc N, Daskalogianni C, Granzhan A, Teulade-Fichou MP, Fahraeus R, Prado Martins R, Blondel M.
    Genes (Basel); 2019 Aug 31; 10(9):. PubMed ID: 31480411
    [Abstract] [Full Text] [Related]

  • 14. In Cellulo Protein-mRNA Interaction Assay to Determine the Action of G-Quadruplex-Binding Molecules.
    Prado Martins R, Findakly S, Daskalogianni C, Teulade-Fichou MP, Blondel M, Fåhraeus R.
    Molecules; 2018 Nov 29; 23(12):. PubMed ID: 30501034
    [Abstract] [Full Text] [Related]

  • 15. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H, Dawany N, Showe L, Lu F, Wikramasinghe P, Lieberman PM.
    J Virol; 2016 Jan 01; 90(1):345-55. PubMed ID: 26468528
    [Abstract] [Full Text] [Related]

  • 16. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL, Liu CD, You RI, Ching YH, Liang J, Ke L, Chen YL, Chen HC, Hsu HJ, Liou JW, Kieff E, Peng CW.
    Proc Natl Acad Sci U S A; 2016 Feb 23; 113(8):2229-34. PubMed ID: 26858444
    [Abstract] [Full Text] [Related]

  • 17. The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA.
    Zheng AJL, Thermou A, Daskalogianni C, Malbert-Colas L, Karakostis K, Le Sénéchal R, Trang Dinh V, Tovar Fernandez MC, Apcher S, Chen S, Blondel M, Fahraeus R.
    Nucleic Acids Res; 2022 Sep 23; 50(17):10110-10122. PubMed ID: 36107769
    [Abstract] [Full Text] [Related]

  • 18. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD, Lee HL, Peng CW.
    J Virol; 2020 Mar 17; 94(7):. PubMed ID: 31941781
    [Abstract] [Full Text] [Related]

  • 19. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
    Apcher S, Daskalogianni C, Manoury B, Fåhraeus R.
    PLoS Pathog; 2010 Oct 14; 6(10):e1001151. PubMed ID: 20976201
    [Abstract] [Full Text] [Related]

  • 20. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.
    Jiang L, Xie C, Lung HL, Lo KW, Law GL, Mak NK, Wong KL.
    Theranostics; 2018 Oct 14; 8(19):5307-5319. PubMed ID: 30555548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.